pharmacogenetics

Progress in treatment for patients with poor ovarian response

Personalising courses of treatment is undoubtedly currently the
most important area of change in the field of medicine. A specific strategy should be designed
depending on each patient’s individual characteristics.

One of the key areas for developing personalised medical healthcare is the use of pharmacogenetics. A patient needs different doses or types of pharmaceutical drugs depending on certain genetic variations. […]

2019-01-23T10:37:32+02:0025 de January de 2019|0 Comments

Have I got poor ovarian response? How should I deal with it?

A patient can be classified as having poor response when the number of oocytes obtained during a cycle of in vitro fertilisation is under what was expected. The criteria generally used to label a patient as a poor responder is when 3 or fewer oocytes are retrieved and she has incredibly low ovarian reserve markers (fundamentally, AMH and AFC). […]

2018-08-01T11:49:34+02:003 de August de 2018|0 Comments

Instituto Bernabeu discovers fertility genetic variants

Following years of research, the Poor Responder Unit at Instituto Bernabeu has, for the first time, discovered the genes that play a role in ovarian reserve. This makes choosing the most appropriate medication for the patient’s genetic make-up possible, thus optimising ovarian response.

[…]

2016-10-13T10:19:12+02:0014 de October de 2016|0 Comments
Do you need help?